These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 30448691)
1. Outcomes and costs of single-step hepatitis C testing in primary care, Birmingham, United Kingdom. Munang M; Smit E; Barnett T; Atherton C; Tahir M; Atabani SF Public Health; 2019 Jan; 166():40-44. PubMed ID: 30448691 [TBL] [Abstract][Full Text] [Related]
2. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ]. Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O; Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783 [TBL] [Abstract][Full Text] [Related]
3. Maximizing Reflexive Hepatitis C Virus (HCV) RNA Testing of HCV Antibody-Reactive Samples Within United States Public Health Laboratories. Johnson LN; Gaynor AM; Wroblewski K; Buss SN J Infect Dis; 2024 May; 229(Supplement_3):S357-S361. PubMed ID: 37739790 [TBL] [Abstract][Full Text] [Related]
4. Twenty-four mini-pool HCV RNA screening in a routine clinical virology laboratory setting: a six-year prospective study. Seme K; Mocilnik T; Poljak M J Virol Methods; 2011 Jan; 171(1):303-5. PubMed ID: 21087636 [TBL] [Abstract][Full Text] [Related]
5. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014. Blackburn NA; Patel RC; Zibbell JE Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667 [TBL] [Abstract][Full Text] [Related]
6. Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014. Coyle C; Viner K; Hughes E; Kwakwa H; Zibbell JE; Vellozzi C; Holtzman D; MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):459-63. PubMed ID: 25950252 [TBL] [Abstract][Full Text] [Related]
7. Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis. Jülicher P; Chulanov VP; Pimenov NN; Chirkova E; Yankina A; Galli C PLoS One; 2019; 14(7):e0219687. PubMed ID: 31310636 [TBL] [Abstract][Full Text] [Related]
8. Testing for HCV: the first step in preventing disease transmission and improving health outcomes for HCV-infected individuals. Ward JW Antivir Ther; 2012; 17(7 Pt B):1397-401. PubMed ID: 23321543 [TBL] [Abstract][Full Text] [Related]
9. The disposition of hepatitis C antibody-positive patients in an urban hospital. Putka B; Mullen K; Birdi S; Merheb M J Viral Hepat; 2009 Nov; 16(11):814-21. PubMed ID: 19842281 [TBL] [Abstract][Full Text] [Related]
10. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV. León P; López JA; Elola C; Domingo CJ; Echevarria JM Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department. Ragan K; Pandya A; Holotnak T; Koger K; Collins N; Swain MG Can J Gastroenterol Hepatol; 2020; 2020():5258289. PubMed ID: 32211349 [TBL] [Abstract][Full Text] [Related]
12. Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens. Irving WL; Smith S; Cater R; Pugh S; Neal KR; Coupland CA; Ryder SD; Thomson BJ; Pringle M; Bicknell M; Hippisley-Cox J J Viral Hepat; 2006 Apr; 13(4):264-71. PubMed ID: 16611193 [TBL] [Abstract][Full Text] [Related]
13. Twenty-four mini-pool HCV RNA screening outside a blood transfusion setting: results of a 2-year prospective study. Seme K; Mocilnik T; Fujs K; Babic DZ; Todorović A; Fras-Stefan T; Poljak M J Virol Methods; 2007 Mar; 140(1-2):218-21. PubMed ID: 17157928 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations. Turner BJ; Rochat A; Lill S; Bobadilla R; Hernandez L; Choi A; Guerrero JA Ann Intern Med; 2019 Dec; 171(12):865-874. PubMed ID: 31791065 [TBL] [Abstract][Full Text] [Related]
15. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa. Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C screening strategies in hemodialysis patients. Saab S; Brezina M; Gitnick G; Martin P; Yee HF Am J Kidney Dis; 2001 Jul; 38(1):91-7. PubMed ID: 11431187 [TBL] [Abstract][Full Text] [Related]
17. Failure to diagnose recent hepatitis C virus infections in London injecting drug users. Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup. Gaudy C; Thevenas C; Tichet J; Mariotte N; Goudeau A; Dubois F J Clin Microbiol; 2005 Apr; 43(4):1722-6. PubMed ID: 15814991 [TBL] [Abstract][Full Text] [Related]
20. Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring. Soulier A; Poiteau L; Rosa I; Hézode C; Roudot-Thoraval F; Pawlotsky JM; Chevaliez S J Infect Dis; 2016 Apr; 213(7):1087-95. PubMed ID: 26333945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]